TrialJournal of the American Heart Association2015

Plasma pro-endothelin-1 peptide concentrations rise in chronic kidney disease and following selective endothelin A receptor antagonism.

Neeraj Dhaun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.